155 related articles for article (PubMed ID: 18787630)
1. Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas.
Hall JM; Saenger JS; Fadare O
Int J Clin Exp Pathol; 2008 Mar; 1(6):524-30. PubMed ID: 18787630
[TBL] [Abstract][Full Text] [Related]
2. The role of CD10 in distinguishing atypical fibroxanthoma from sarcomatoid (spindle cell) squamous cell carcinoma.
Wieland CN; Dyck R; Weenig RH; Comfere NI
J Cutan Pathol; 2011 Nov; 38(11):884-8. PubMed ID: 21883368
[TBL] [Abstract][Full Text] [Related]
3. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases.
Buonaccorsi JN; Plaza JA
Am J Dermatopathol; 2012 Jun; 34(4):404-11. PubMed ID: 22257901
[TBL] [Abstract][Full Text] [Related]
4. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
5. Utility of p63 in the differential diagnosis of atypical fibroxanthoma and spindle cell squamous cell carcinoma.
Gleason BC; Calder KB; Cibull TL; Thomas AB; Billings SD; Morgan MB; Hiatt KM; Smoller BR
J Cutan Pathol; 2009 May; 36(5):543-7. PubMed ID: 19476522
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining of CD10 in atypical fibroxanthomas.
Hultgren TL; DiMaio DJ
J Cutan Pathol; 2007 May; 34(5):415-9. PubMed ID: 17448198
[TBL] [Abstract][Full Text] [Related]
7. p63 is a useful marker for cutaneous spindle cell squamous cell carcinoma.
Dotto JE; Glusac EJ
J Cutan Pathol; 2006 Jun; 33(6):413-7. PubMed ID: 16776716
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical distinction of cutaneous spindle cell carcinoma.
Morgan MB; Purohit C; Anglin TR
Am J Dermatopathol; 2008 Jun; 30(3):228-32. PubMed ID: 18496422
[TBL] [Abstract][Full Text] [Related]
9. Expression of the p40 isoform of p63 has high specificity for cutaneous sarcomatoid squamous cell carcinoma.
Ha Lan TT; Chen SJ; Arps DP; Fullen DR; Patel RM; Siddiqui J; Carskadon S; Palanisamy N; Harms PW
J Cutan Pathol; 2014 Nov; 41(11):831-8. PubMed ID: 25263756
[TBL] [Abstract][Full Text] [Related]
10. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies.
Henderson SA; Torres-Cabala CA; Curry JL; Bassett RL; Ivan D; Prieto VG; Tetzlaff MT
Am J Surg Pathol; 2014 Aug; 38(8):1102-10. PubMed ID: 25029117
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of CD10 and procollagen 1 expression in atypical fibroxanthoma and dermatofibroma.
de Feraudy S; Mar N; McCalmont TH
Am J Surg Pathol; 2008 Aug; 32(8):1111-22. PubMed ID: 18545147
[TBL] [Abstract][Full Text] [Related]
12. PRAME expression in spindle cell melanoma, malignant peripheral nerve sheath tumour, and other cutaneous sarcomatoid neoplasms: a comparative analysis.
Hrycaj SM; Szczepanski JM; Zhao L; Siddiqui J; Thomas DG; Lucas DR; Patel RM; Harms PW; Bresler SC; Chan MP
Histopathology; 2022 Dec; 81(6):818-825. PubMed ID: 36102613
[TBL] [Abstract][Full Text] [Related]
13. Spindle-cell and pleomorphic neoplasms of the skin. A clinicopathologic and immunohistochemical study of 30 cases, with emphasis on "atypical fibroxanthomas".
Silvis NG; Swanson PE; Manivel JC; Kaye VN; Wick MR
Am J Dermatopathol; 1988 Feb; 10(1):9-19. PubMed ID: 3177827
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma.
Bull C; Mirzabeigi M; Laskin W; Dubina M; Traczyc T; Guitart J; Gerami P
J Cutan Pathol; 2011 Aug; 38(8):631-5. PubMed ID: 21623867
[TBL] [Abstract][Full Text] [Related]
15. Sarcomatoid Carcinoma With Quasi-Complete Loss of Cytokeratin Expression or Keratin-Positive Atypical Fibroxanthoma.
Roy SF; Lafaille P; Désy D
Int J Surg Pathol; 2019 Aug; 27(5):518-520. PubMed ID: 30760056
[TBL] [Abstract][Full Text] [Related]
16. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
[TBL] [Abstract][Full Text] [Related]
17. p40 is a more specific marker than p63 for cutaneous poorly differentiated squamous cell carcinoma.
Alomari AK; Glusac EJ; McNiff JM
J Cutan Pathol; 2014 Nov; 41(11):839-45. PubMed ID: 25263848
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous Spindle Cell Squamous Cell Carcinoma in Cats: Clinical, Histological, and Immunohistochemical Study.
Rodríguez Guisado F; Suárez-Bonnet A; Ramírez GA
Vet Pathol; 2021 May; 58(3):503-507. PubMed ID: 33577428
[TBL] [Abstract][Full Text] [Related]
19. Focal Anomalous Expression of Cytokeratin and p63 in Malignant Phyllodes Tumor: A Comparison With Spindle Cell Metaplastic Carcinoma.
Bansal M; Chen J; Wang X
Appl Immunohistochem Mol Morphol; 2018 Mar; 26(3):198-201. PubMed ID: 28968268
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of CD163 in cutaneous spindle cell lesions.
Pouryazdanparast P; Yu L; Cutlan JE; Olsen SH; Fullen DR; Ma L
J Cutan Pathol; 2009 Aug; 36(8):859-64. PubMed ID: 19040468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]